About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
May 2024 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Twitter List
Legislative Tracking Tools
Category Archives: Pharma Industry Image
Earthquake Hits! The Tectonic Plates of Trust Shift
An earthquake struck the area where I grew up last week and again this weekend in southern Illinois. Shocking. But it wasn’t the first earthquake of the week. Aftershocks continue. The JAMA report last week measured very high on the … Continue reading
Posted in Pharma Industry Image
Comments Off on Earthquake Hits! The Tectonic Plates of Trust Shift
A Reimbursement Policy to Die For
The image of the pharmaceutical industry has seen some battering. Pricing issues, recalls, product withdrawals, clinical trial practices, me-too products, some marketing efforts, all have eroded the image of the industry that in essence often brings miracles and therefore people … Continue reading
Posted in Pharma Industry Image
Comments Off on A Reimbursement Policy to Die For
Heparin – Out of Adversity Comes Opportunity
The recent issues involving safety and the blood-thinner Heparin have dominated pharma news lately. While it is one more story about dangers with a drug product that were not anticipated, it stands out on its own. That is because it … Continue reading
Posted in Pharma Industry Image
5 Comments
Corporate Use of Blogging – Johnson & Johnson and the Lawsuit
As noted here previously, the Johnson and Johnson blog launched by the company – JNJ BTW – is an unusual and bold experiment in new media and pharma. Since its launch, the blog has covered a range of topics, trying … Continue reading
Posted in Pharma Industry Image
9 Comments
The Summer of SiCKO – Cannes Film Festival Begins Today
Many people have strong feelings about film/documentary producer Michael Moore. Actually, I have to confess, I’ve never seen one of his films, but I would like to one day. In any case, his current work, SiCKO has been selected as … Continue reading
Posted in Pharma Industry Image
1 Comment